Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Genetic Technologies ( (AU:GTG) ) has issued an update.
Genetic Technologies Limited announced significant changes in its board of directors following a General Meeting of shareholders. Three directors, George Muchnicki, Peter Rubinstein, and Lindsay Wakefield, have resigned, and Michael Walker, Anthony Hartman, and John Polinelli have been appointed as non-executive directors. These changes are expected to bring new perspectives and expertise to the company’s strategic direction.
More about Genetic Technologies
Genetic Technologies Limited operates in the biotechnology industry, focusing on genetic testing and diagnostics. The company is known for its innovative genetic testing solutions that cater to both healthcare providers and consumers, aiming to enhance personalized medicine and preventive healthcare.
Technical Sentiment Signal: Sell
Current Market Cap: A$9.45M
Find detailed analytics on GTG stock on TipRanks’ Stock Analysis page.